Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ultrasound-Guided ventilation may shorten time on ventilator for ARDS patients

NCT ID NCT04966624

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new ventilation strategy for patients with a specific type of acute respiratory distress syndrome (ARDS) called focal ARDS. The strategy uses lung ultrasound to guide ventilator settings, early prone positioning, and adjustments based on body mass index. The goal is to see if this approach reduces the number of days patients need a ventilator compared to standard care. The trial plans to enroll 84 adults who have been on a ventilator for less than 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ventilation strategy using APRV mode, early prone sessions, and PEEP adjustment based on BMI
What this could lead to
If successful, this could reduce the number of days patients with focal ARDS need a ventilator, potentially improving recovery and reducing complications.
What could go wrong
This is a small, early-stage trial (84 participants) testing a bundle of measures. Previous similar research failed to show a survival benefit, and the approach may not work for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2021

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * person who has given oral consent or has been included in an emergency * Older than 18 years * On mechanical ventilation for less than 24 hours * Diagnosis of ARDS for less than 24 hours. ARDS according to the Berlin classification: i.e. arterial oxygen pressure to inspired oxygen fraction ratio less than or equal to 300, with a PEEP greater than or equal to 5, presence of bilateral radiological infiltrates not fully explained by heart failure or volume overload * Focal ARDS determined on pulmonary ultrasound Exclusion Criteria: * person who is not a beneficiary of national health insurance * person who is subject to a legal measure of protection (curatorship, guardianship) * pregnant or breastfeeding women * minor * Patient having benefited from an invasive mechanical ventilation of more than one week in the previous month; * ARDS in the previous month; * Chronic respiratory failure under NIV or long term oxygen; * Severe acute asthma; * Lobectomy; * Pneumothorax; * Pneumomediastinum; * Pulmonary fibrosis; * Morbid obesity with a BMI above 40 ; * Cancer with metastasis; * Bone marrow transplantation; * Chemotherapy-induced neutropenia; * Cirrhosis with a Child-Pugh score of C; * Suspected or confirmed intracranial hypertension; * Concurrent participation in another ARDS study; * Extensive burns on the torso.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Focal acute respiratory distress syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Chu Dijon Bourgogne

    RECRUITING

    Dijon, 21000, France